PortfoliosLab logoPortfoliosLab logo
UTHR vs. EWY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

UTHR vs. EWY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and iShares MSCI South Korea ETF (EWY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 12.77% return, which is significantly lower than EWY's 119.05% return. Both investments have delivered pretty close results over the past 10 years, with UTHR having a 16.80% annualized return and EWY not far ahead at 17.46%.


UTHR

1D
1.74%
1M
-5.46%
YTD
12.77%
6M
14.24%
1Y
69.48%
3Y*
36.25%
5Y*
25.58%
10Y*
16.80%

EWY

1D
-0.73%
1M
30.18%
YTD
119.05%
6M
134.13%
1Y
251.82%
3Y*
51.99%
5Y*
20.31%
10Y*
17.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. EWY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
12.77%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
EWY
iShares MSCI South Korea ETF
119.05%95.33%-20.48%19.05%-26.59%-7.58%39.43%7.97%-20.37%44.97%

Correlation

The correlation between UTHR and EWY is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since May 15, 2000

0.25

The correlation between UTHR and EWY shifts across timeframes, from 0.06 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. EWY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 8686
Overall Rank
UTHR Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 8686
Sortino Ratio Rank
UTHR Omega Ratio Rank: 8686
Omega Ratio Rank
UTHR Calmar Ratio Rank: 8888
Calmar Ratio Rank
UTHR Martin Ratio Rank: 8888
Martin Ratio Rank

EWY
EWY Risk / Return Rank: 9696
Overall Rank
EWY Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
EWY Sortino Ratio Rank: 9595
Sortino Ratio Rank
EWY Omega Ratio Rank: 9595
Omega Ratio Rank
EWY Calmar Ratio Rank: 9797
Calmar Ratio Rank
EWY Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. EWY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and iShares MSCI South Korea ETF (EWY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTHREWYDifference
Sharpe ratioReturn per unit of total volatility

-4.62

Sortino ratioReturn per unit of downside risk

-2.49

Omega ratioGain probability vs. loss probability

1.38

1.74

-0.36

Calmar ratioReturn relative to maximum drawdown

4.27

10.99

-6.72

Martin ratioReturn relative to average drawdown

11.01

40.91

-29.89

UTHR vs. EWY - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.40, which is lower than the EWY Sharpe Ratio of 6.02. The chart below compares the historical Sharpe Ratios of UTHR and EWY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UTHREWYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.40

6.02

-4.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.73

0.71

+0.02

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

0.64

-0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

0.33

+0.05

Drawdowns

UTHR vs. EWY - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than EWY's maximum drawdown of -74.14%. Use the drawdown chart below to compare losses from any high point for UTHR and EWY.


Loading charts...

Drawdown Indicators


UTHREWYDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-74.14%

-19.04%

Max Drawdown (1Y)

Largest decline over 1 year

-16.35%

-23.08%

+6.73%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-27.36%

-5.64%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-48.55%

+15.55%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-49.73%

-5.83%

Current Drawdown

Current decline from peak

-7.92%

-1.73%

-6.19%

Average Drawdown

Average peak-to-trough decline

-35.32%

-20.13%

-15.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.33%

6.19%

+0.14%

Volatility

UTHR vs. EWY - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 8.33%, while iShares MSCI South Korea ETF (EWY) has a volatility of 20.32%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than EWY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHREWYDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.33%

20.32%

-11.99%

Volatility (6M)

Calculated over the trailing 6-month period

26.06%

37.41%

-11.35%

Volatility (1Y)

Calculated over the trailing 1-year period

49.78%

42.10%

+7.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.15%

28.83%

+6.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.10%

27.37%

+7.73%

Dividends

UTHR vs. EWY - Dividend Comparison

UTHR has not paid dividends to shareholders, while EWY's dividend yield for the trailing twelve months is around 0.96%.


PositionTTM20252024202320222021202020192018201720162015
EWY
iShares MSCI South Korea ETF
0.96%2.10%2.55%2.52%1.23%2.16%0.73%2.10%1.34%2.90%1.21%2.42%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


UTHR and EWY have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EWY has higher volatility (20.32%) compared to UTHR (8.33%). In terms of maximum drawdown, UTHR dropped -93.18% vs EWY's -74.14%.

EWY currently has the higher Sharpe Ratio (6.02 vs 1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and EWY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer